Is preoperative weight reduction of living-donor liver transplant recipients and donors harmful to postoperative outcomes?

被引:0
作者
Yoshiya, Shohei [1 ]
Itoh, Shinji [1 ]
Toshima, Takeo [1 ]
Izumi, Takuma [1 ]
Iseda, Norifumi [1 ]
Tsutsui, Yuriko [1 ]
Toshida, Katsuya [1 ]
Nakayama, Yuki [1 ]
Ishikawa, Takuma [1 ]
Tanaka, Yasushi [1 ,2 ]
Ninomiya, Mizuki [1 ]
Yoshizumi, Tomoharu [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka, Japan
关键词
Donor weight reduction; Living -donor liver transplantation; Postoperative outcomes; Preoperative weight reduction; Recipient weight reduction; BODY-MASS INDEX; HEPATIC STEATOSIS; FATTY LIVER; OVERWEIGHT; SAFETY;
D O I
10.1016/j.gassur.2024.04.010
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Purpose: Although the incidence of recipients and donors with overweight and obesity is increasing worldwide, few reports have focused on outcomes of preoperative weight reduction (WR) in living-donor liver transplantation (LDLT). Therefore, we examined the outcomes and the impact of WR on the postoperative course. Methods: We analyzed 217 consecutive LDLT procedures performed from 2017 to 2022. We divided the recipients and donors into a WR group and non-WR group. Results: Twenty-two recipients (10.1%) achieved WR (preoperative recipient WR [RWR] group), reducing their weight by 6.8% +/- 6.0% within 2.2 +/- 1.4 months with a significant decrease in body mass index (BMI) (P < .0001). The RWR group showed no significant differences in short-term postoperative outcomes (operative factors, postoperative liver function tests, amount of ascites, and morbidity) or in the graft survival rate as a long-term outcome (P = .24) compared with the non-RWR group. Forty-one donors (18.9%) achieved WR (preoperative donor WR [DWR] group), reducing their weight by 9.7% +/- 6.3% within 3.2 +/- 5.8 months with a significant decrease in BMI (P < .0001). Compared with the non-DWR group, the DWR group showed no significant differences in short-term postoperative outcomes between themselves and recipients or in the graft survival rate (P = .49). Furthermore, WR resulted in an increase to 32 donor-eligible and 6 recipient-eligible patients. Conclusion: WR in LDLT recipients and donors had no harmful effect on postoperative outcomes and should lead to increase recipients' chance of undergoing LDLT and to expand the donor pool. (c) 2024 Society for Surgery of the Alimentary Tract. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:1033 / 1038
页数:6
相关论文
共 50 条
  • [31] Outcomes of pediatric identical living-donor liver and hematopoietic stem cell transplantation
    Hartleif, Steffen
    Lang, Peter
    Handgretinger, Rupert
    Feuchtinger, Tobias
    Fuchs, Joerg
    Koenigsrainer, Alfred
    Nadalin, Silvio
    Sturm, Ekkehard
    PEDIATRIC TRANSPLANTATION, 2016, 20 (07) : 888 - 897
  • [32] Non-alcoholic fatty liver disease and obesity among adult donors are major challenges to living-donor liver transplantation: A single-center experience
    Rajaram, Ruveena B.
    Jayaraman, Thevaraajan
    Yoong, Boon-Koon
    Koh, Peng-Soon
    San Loh, Pui
    Koong, Jun-Kit
    Khalil, Alizan A.
    Hashim, Noorjahan Haneem Md
    Jamaluddin, Fadhil H.
    Mahadeva, Sanjiv
    ASIAN JOURNAL OF SURGERY, 2022, 45 (01) : 441 - 447
  • [33] Effect of Sarcopenic Obesity on Outcomes of Living-Donor Liver Transplantation for Hepatocellular Carcinoma
    Itoh, Shinji
    Yoshizumi, Tomoharu
    Kimura, Koichi
    Okabe, Hirohisa
    Harimoto, Norifumi
    Ikegami, Toru
    Uchiyama, Hideaki
    Shirabe, Ken
    Nishie, Akihiro
    Maehara, Yoshihiko
    ANTICANCER RESEARCH, 2016, 36 (06) : 3029 - 3034
  • [34] Short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation
    Nakamuta, M
    Morizono, S
    Soejima, Y
    Yoshizumi, T
    Aishima, S
    Takasugi, S
    Yoshimitsu, K
    Enjoji, M
    Kotoh, K
    Taketomi, A
    Uchiyama, H
    Shimada, M
    Nawata, H
    Maehara, Y
    TRANSPLANTATION, 2005, 80 (05) : 608 - 612
  • [35] Influence of CYP2C19 genotypes on graft pathological findings and postoperative liver function in recipients after living-donor liver transplantation
    Chiu, King-Wah
    Nakano, Toshiaki
    Hu, Tsung-Hui
    Tseng, Hui-Peng
    Cheng, Yu-Fan
    Jawan, Bruno
    Eng, Hock-Liew
    Goto, Shigeru
    Chen, Chao-Long
    ANNALS OF TRANSPLANTATION, 2010, 15 (04) : 38 - 43
  • [36] Evaluation and Management of Living Donors in the Setting of Living Donor Liver Transplant Program in the Republic of Uzbekistan
    Semash, Konstantin
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2024, 22 (09) : 664 - 674
  • [37] Changes in Indices of Steatosis and Fibrosis in Liver Grafts of Living Donors After Weight Reduction
    Choi, Jaehyuk
    Choi, YoungRok
    Hong, Su Young
    Suh, Sanggyun
    Hong, Kwangpyo
    Han, Eui Soo
    Lee, Jeong-Moo
    Hong, Suk Kyun
    Yi, Nam-Joon
    Lee, Kwang-Woong
    Suh, Kyung-Suk
    FRONTIERS IN SURGERY, 2022, 9
  • [38] Investigation of actual daily lifestyle leading to continuous self-management after living-donor liver transplantation: More than 5years living with living-donor liver transplantation and emotions of recipients
    Akazawa, Chiharu
    Nishizono, Teiko
    Yamamoto, Masae
    Teraguchi, Sayoko
    Hayashi, Yuko
    JAPAN JOURNAL OF NURSING SCIENCE, 2013, 10 (01) : 79 - 88
  • [39] Cytokine concentrations and regulatory T cells in living donor and deceased donor liver transplant recipients
    Briem-Richter, Andrea
    Leuschner, Alexander
    Haag, Friedrich
    Grabhorn, Enke
    Ganschow, Rainer
    PEDIATRIC TRANSPLANTATION, 2013, 17 (02) : 185 - 190
  • [40] Expression of alpha smooth muscle actin in living donor liver transplant recipients
    Masataka Hirabaru
    Kyoko Mochizuki
    Mitsuhisa Takatsuki
    Akihiko Soyama
    Taiichiro Kosaka
    Tamotsu Kuroki
    Isao Shimokawa
    Susmu Eguchi
    World Journal of Gastroenterology, 2014, (22) : 7067 - 7074